Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Stallmach

Showing results (31-40 of 318) with videos related to

Pageof 32
Sort By:
Best Practice & Research. Clinical Gastroenterology|March 16, 2010
Adverse effects of biologics used for treating IBDAndreas Stallmach, Stefan Hagel, Tony Bruns
Deutsches Arzteblatt International|March 31, 2021
Post-Test Probability of COVID-19 Using CTUlf Teichgräber, Wilhelm Behringer, Andreas Stallmach
Journal of Crohn'S & Colitis|June 21, 2011
Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot studyWinfried Häuser, Carsten Schmidt, Andreas Stallmach
MMW Fortschritte Der Medizin|August 28, 2025
[Therapy of Clostridioides difficile infection]Katrin Katzer, Kathleen Lange, Andreas Stallmach
International Journal of Colorectal Disease|October 24, 2020
Appendectomy in childhood-did it save my sibling from getting ulcerative colitis?Niels Teich, Tony Bruns, Andreas Stallmach, et al.
Journal of Crohn'S & Colitis|April 17, 2018
Ustekinumab Rescue Therapy in a Patient With Chronic Refractory PouchitisJack Peter, Jonas Zeitz, Andreas Stallmach
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challengesArndt Steube, Johannes Stallhofer, Andreas Stallmach
World Journal of Gastroenterology|March 15, 2014
Risk factors and outcome of bacterial infections in cirrhosisTony Bruns, Henning W Zimmermann, Andreas Stallmach
BMC Gastroenterology|August 23, 2023
Fatigue in patients with inflammatory bowel disease-strongly influenced by depression and not identifiable through laboratory testing: a cross-sectional survey studyVictoria Uhlir, Andreas Stallmach, Philip Christian Grunert
Frontiers in Pharmacology|April 29, 2021
An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' PerspectiveCarsten Schmidt, Philip C Grunert, Andreas Stallmach
Pageof 32

Showing results (31-40 of 318) with videos related to

Sort By:
Pageof 32
Best Practice & Research. Clinical Gastroenterology|March 16, 2010
Adverse effects of biologics used for treating IBDAndreas Stallmach, Stefan Hagel, Tony Bruns
Deutsches Arzteblatt International|March 31, 2021
Post-Test Probability of COVID-19 Using CTUlf Teichgräber, Wilhelm Behringer, Andreas Stallmach
Journal of Crohn'S & Colitis|June 21, 2011
Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot studyWinfried Häuser, Carsten Schmidt, Andreas Stallmach
MMW Fortschritte Der Medizin|August 28, 2025
[Therapy of Clostridioides difficile infection]Katrin Katzer, Kathleen Lange, Andreas Stallmach
International Journal of Colorectal Disease|October 24, 2020
Appendectomy in childhood-did it save my sibling from getting ulcerative colitis?Niels Teich, Tony Bruns, Andreas Stallmach, et al.
Journal of Crohn'S & Colitis|April 17, 2018
Ustekinumab Rescue Therapy in a Patient With Chronic Refractory PouchitisJack Peter, Jonas Zeitz, Andreas Stallmach
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challengesArndt Steube, Johannes Stallhofer, Andreas Stallmach
World Journal of Gastroenterology|March 15, 2014
Risk factors and outcome of bacterial infections in cirrhosisTony Bruns, Henning W Zimmermann, Andreas Stallmach
BMC Gastroenterology|August 23, 2023
Fatigue in patients with inflammatory bowel disease-strongly influenced by depression and not identifiable through laboratory testing: a cross-sectional survey studyVictoria Uhlir, Andreas Stallmach, Philip Christian Grunert
Frontiers in Pharmacology|April 29, 2021
An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' PerspectiveCarsten Schmidt, Philip C Grunert, Andreas Stallmach
Pageof 32